Thomas von Erlach
Co-founder and CEO of Vivtex and former postdoc in the Langer Lab at MIT, focused on developing orally available biologics and securing industry partnerships such as the Novo Nordisk collaboration.
Best podcasts with Thomas von Erlach
Ranked by the Snipd community
24 snips
Mar 2, 2026 • 54min
Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.
Thomas von Erlach, Ph.D., co-founder and CEO of Vivtex and former Langer Lab postdoc, works on making biologics orally available. He discusses founding Vivtex from MIT work, using a GI-tract-on-a-chip platform, earning long-term pharma trust, and striking a major Novo Nordisk partnership. Conversations cover stealth development, translating assays to pills, and scaling from CSO to CEO.
